"We are thrilled to be able to offer the only FDA-approved long-term therapy for people suffering from advanced RP, " said Robert Greenberg, MD, PhD, President and CEO of Second Sight.
ENGADGET: FDA clears Argus II 'bionic eye' for sale in the US (video)